Oruka Therapeutics (ORKA) Earnings Analysis
Oruka Therapeutics (ORKA) next reports earnings on 2026-08-10, consensus EPS -0.49 USD. Last quarter (2026-03-12) it beat with EPS -0.45 USD vs -0.61 USD est (+26.2%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -38.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ORKA next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.49 USD |
| Revenue estimate | n/a |
ORKA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -0.45 USD | -0.61 USD | +26.2% | Beat |
| 2025-11-12 | -0.55 USD | -0.56 USD | +1.8% | Beat |
| 2025-08-11 | -0.46 USD | -0.48 USD | +4.2% | Beat |
| 2025-03-06 | -0.49 USD | -0.68 USD | +27.9% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
ORKA valuation and analyst view
| Trailing P/E | -38.72 |
|---|---|
| Trailing EPS | -2.1071 USD |
| Price / book | 10.49 |
| Dividend yield | 0.00% |
| Market cap | 3.49B |
| Analyst consensus | Buy (9 buy / 0 hold / 0 sell) |
| Avg price target | 147.33 USD |
Related research pages
Frequently asked questions
When is Oruka Therapeutics (ORKA)'s next earnings date?
Oruka Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.49 USD.
Did ORKA beat earnings last quarter?
In its 2026-03-12 report, ORKA posted EPS of -0.45 USD versus a -0.61 USD estimate — a beat of 26.2%.
What is ORKA's earnings track record?
Over the last 4 reported quarters with consensus data, ORKA beat estimates 4 times (100%).
What is ORKA's current P/E ratio and EPS?
ORKA trades at a trailing P/E of -38.72 on trailing EPS of -2.1071038948633927 USD.
What do analysts rate ORKA?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 147.33 USD.